Micaela Dines, Adriana Bulacia, Paloma Bamondez, Irene Luis Vega, Micaela Montenegro, Pablo Germán Díaz, Paula Oyhamburu, Ana Laura Ramos, Florencia Ambrosio, Gustavo Vázquez
{"title":"Subanesthetic Dose Ketamine Infusions for Treatment-Resistant Major Depression: An Application Protocol at a Public Hospital in Argentina","authors":"Micaela Dines, Adriana Bulacia, Paloma Bamondez, Irene Luis Vega, Micaela Montenegro, Pablo Germán Díaz, Paula Oyhamburu, Ana Laura Ramos, Florencia Ambrosio, Gustavo Vázquez","doi":"10.53680/vertex.v36i168.832","DOIUrl":null,"url":null,"abstract":"<p><p>Treatment-resistant major depression (TRD) poses a significant challenge in psychiatry due to the limited response to conventional therapies. Subanesthetic dose intravenous (IV) ketamine has emerged as an effective therapeutic option, providing rapid effects on depressive and suicidal symptoms. This article outlines the ketamine infusion protocol implemented in a general hospital, following international guidelines. Inclusion and exclusion criteria, dosage, administration procedure, and patient monitoring. Additionally, adverse effects and safety considerations. The implementation of this protocol optimizes the use of ketamine in TRD, ensuring both efficacy and safety.</p>","PeriodicalId":75297,"journal":{"name":"Vertex (Buenos Aires, Argentina)","volume":"36 168, abr.- jun.","pages":"33-38"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vertex (Buenos Aires, Argentina)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53680/vertex.v36i168.832","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Treatment-resistant major depression (TRD) poses a significant challenge in psychiatry due to the limited response to conventional therapies. Subanesthetic dose intravenous (IV) ketamine has emerged as an effective therapeutic option, providing rapid effects on depressive and suicidal symptoms. This article outlines the ketamine infusion protocol implemented in a general hospital, following international guidelines. Inclusion and exclusion criteria, dosage, administration procedure, and patient monitoring. Additionally, adverse effects and safety considerations. The implementation of this protocol optimizes the use of ketamine in TRD, ensuring both efficacy and safety.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
